Product Information

LEVOCETIRIZINE 2.5 MG/5 ML SOL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1659 per ML under NDC 45802068028. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Nov 7, 2011. Its Orange Book therapeutic-equivalence code is AA.

LEVOCETIRIZINE 2.5 MG/5 ML SOL

Levocetirizine dihydrochloride
$0.1659per ML

Strength

.5 mg/mL

NDC

45802068028

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091263

FDA Approved

11/7/2011

TE Code

AA

On Market Since

11/7/2011

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 60.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1659 per ML
All-time high$0.5031 (Apr 15, 2015)
All-time low$0.1171 (Sep 22, 2021)
52-week high$0.1740
52-week low$0.1409
Median price$0.3186
Average price$0.3184
Largest weekly change+68.3% (Dec 22, 2021)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+4.9%

1M

+4.9%

3M

+10.7%

6M

+11.9%

1Y

-4.7%

3Y

-25.0%

5Y

-45.0%

All

-60.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levocetirizine dihydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LEVOCETIRIZINE 2.5 MG/5 ML SOL?

The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 2.5 MG/5 ML SOL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1659 per ML (NDC 45802068028), effective Aug 19, 2026.

How has the price of LEVOCETIRIZINE 2.5 MG/5 ML SOL changed over time?

Over the history we have for it, the NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has declined 60.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 2.5 MG/5 ML SOL?

Since Nov 28, 2013, the NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has ranged from a low of $0.1171 (Sep 22, 2021) to a high of $0.5031 (Apr 15, 2015), with a median of $0.3186 per ML.

Are there cheaper alternatives to LEVOCETIRIZINE 2.5 MG/5 ML SOL?

No other NADAC-published product currently shares the active ingredient and strength of LEVOCETIRIZINE 2.5 MG/5 ML SOL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LEVOCETIRIZINE 2.5 MG/5 ML SOL?

LEVOCETIRIZINE 2.5 MG/5 ML SOL (NDC 45802068028) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.